Holen Sie sich die Stockscreener-App
74.81
1.19%
0.88
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt EW?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$73.93
Offen:
$73.3
24-Stunden-Volumen:
13.12M
Relative Volume:
2.44
Marktkapitalisierung:
$44.12B
Einnahmen:
$6.60B
Nettoeinkommen (Verlust:
$4.16B
KGV:
31.97
EPS:
2.34
Netto-Cashflow:
$490.10M
1W Leistung:
+2.03%
1M Leistung:
+7.58%
6M Leistung:
-15.79%
1J Leistung:
+0.93%
1-Tages-Spanne:
$72.97
$75.27
1-Wochen-Bereich:
$72.29
$75.27
52-Wochen-Spanne:
$58.93
$96.12
Edwards Lifesciences Corp Stock (EW) Company Profile
Firmenname
Edwards Lifesciences Corp
Sektor
Branche
Telefon
(949) 250-2500
Adresse
ONE EDWARDS WAY, IRVINE, CA
Vergleichen Sie EW mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EW
Edwards Lifesciences Corp
|
74.81 | 44.12B | 6.60B | 4.16B | 490.10M | 6.93 |
|
ABT
Abbott Laboratories
|
114.23 | 198.13B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
364.60 | 138.99B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
88.95 | 131.10B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
81.03 | 103.90B | 33.00B | 4.29B | 5.50B | 3.27 |
Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-10-11 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-09-18 | Herabstufung | Jefferies | Buy → Hold |
| 2024-07-31 | Hochstufung | Daiwa Securities | Neutral → Outperform |
| 2024-07-29 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2024-07-25 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-07-25 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-07-25 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-07-25 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-07-25 | Herabstufung | Truist | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-05-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-05-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-03-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-02-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-11-28 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2023-09-26 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-03-08 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-02-06 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-31 | Herabstufung | Bernstein | Outperform → Underperform |
| 2023-01-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-12-06 | Herabstufung | Stifel | Buy → Hold |
| 2022-10-28 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-10-26 | Eingeleitet | Mizuho | Buy |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-29 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-03-16 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2022-02-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-27 | Bestätigt | Citigroup | Buy |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Raymond James | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | UBS | Neutral |
| 2021-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-12-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-07-30 | Bestätigt | Canaccord Genuity | Buy |
| 2021-07-30 | Bestätigt | Deutsche Bank | Hold |
| 2021-07-30 | Bestätigt | Jefferies | Buy |
| 2021-07-30 | Bestätigt | Morgan Stanley | Overweight |
| 2021-07-30 | Bestätigt | Oppenheimer | Outperform |
| 2021-07-30 | Bestätigt | Stifel | Buy |
| 2021-07-30 | Bestätigt | UBS | Neutral |
| 2021-07-30 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Neutral |
| 2021-04-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-11 | Bestätigt | Canaccord Genuity | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Underperform |
| 2020-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Neutral |
| 2020-01-10 | Eingeleitet | Oppenheimer | Outperform |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-10-24 | Bestätigt | Canaccord Genuity | Buy |
| 2019-09-23 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-07-24 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-18 | Bestätigt | Canaccord Genuity | Buy |
| 2019-01-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Hold |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-10-16 | Eingeleitet | Barclays | Underweight |
| 2018-10-02 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2018-10-02 | Herabstufung | Guggenheim | Buy → Neutral |
Alle ansehen
Edwards Lifesciences Corp Aktie (EW) Neueste Nachrichten
Jim Cramer: Is Edwards Lifesciences (EW) Poised for a Comeback? - Insider Monkey
Dominican Republic: A Strategic Destination Attracting Multimillion-Dollar Investments - GlobeNewswire Inc.
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch
Edwards Lifesciences Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
EDWARDS ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Edwards lifesciences CVP Daniel Lippis sells $185k in stock By Investing.com - Investing.com Australia
Edwards Lifesciences Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Edwards lifesciences CVP Daniel Lippis sells $185k in stock - Investing.com India
Edwards Lifesciences' SWOT analysis: stock outlook amid TAVR challenges and TMTT growth - Investing.com
Daniel J. Lippis Sells 2,500 Shares of Edwards Lifesciences Co. (NYSE:EW) Stock - MarketBeat
Assessing Edwards Lifesciences: Insights From 20 Financial Analysts - Benzinga
Edwards Lifesciences shares upgraded to buy, target lifted on trajectory - Investing.com
Bank of America Upgrades Edwards Lifesciences (NYSE:EW) to "Buy" - MarketBeat
Synovus Financial Corp Sells 13,938 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
TD Private Client Wealth LLC Sells 17,777 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Co. (NYSE:EW) Given Consensus Rating of "Hold" by Analysts - MarketBeat
M&T Bank Corp Reduces Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
EW DEADLINE TODAY: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Edwards Lifesciences - The Bakersfield Californian
EW DEADLINE TODAY: ROSEN, TOP RANKED GLOBAL COUNSEL, - GlobeNewswire
Faruqi & Faruqi Reminds Edwards Lifesciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024EW - Newsfile
Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now? - Yahoo Finance
Peapack Gladstone Financial Corp Grows Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Zacks Research Issues Optimistic Forecast for EW Earnings - MarketBeat
World Investment Advisors LLC Purchases 68,172 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Teachers Retirement System of The State of Kentucky Has $9.16 Million Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) completed the acquisition of 93% stake in Endotronix Inc. for approximately $800 million - Marketscreener.com
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Edwards Lifesciences Corporation (EW) - Business Wire
Virtu Financial LLC Takes Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Co. (NYSE:EW) Shares Bought by Geode Capital Management LLC - MarketBeat
FRIDAY INVESTOR DEADLINE: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitEW - AccessWire
Neo Ivy Capital Management Purchases New Shares in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
INVESTOR DEADLINE TOMORROW: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
Edwards Lifesciences Corporation Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm Before December 13, 2024 to Discuss Your RightsEW - Marketscreener.com
Nomura Asset Management Co. Ltd. Reduces Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Corp. stock rises Wednesday, still underperforms market - MarketWatch
EW INVESTOR ALERT: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit - The Eastern Progress Online
EW INVESTOR NOTICE: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - The Eastern Progress Online
EW Deadline: Rosen Law Firm Urges Edwards Lifesciences Corporation (NYSE: EW) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
EW FRAUD CLASS ACTION: BFA Law Notifies Edwards Lifesciences Investors of the Ongoing Class Action and Encourages You to Contact the Firm before December 13 Deadline - Newsfile
Stifel Financial Corp Boosts Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Edwards Lifesciences Co. (NYSE:EW) Stock Position Boosted by Public Employees Retirement System of Ohio - MarketBeat
Kovitz Investment Group Partners LLC Acquires 9,093 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
EDWARDS ALERT: Bragar Eagel & Squire, P.C. Reminds - GlobeNewswire
Edwards bullish on TAVR, long-term growth at investor day - BioWorld Online
Conway Capital Management Inc. Invests $737,000 in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
National Bank of Canada FI Has $20.05 Million Stock Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Class Action Lawsuit Against Edwards Lifesciences Corp. (NYSE:EW) - TipRanks
Is Edwards Lifesciences Stock Underperforming The S&P 500? - Barchart
Edwards Lifesciences CFO Scott Ullem sells $806k in stock By Investing.com - Investing.com South Africa
Edwards Lifesciences exec sells $358,750 in stock By Investing.com - Investing.com Nigeria
Edwards Lifesciences exec sells $358,750 in stock - Investing.com
Finanzdaten der Edwards Lifesciences Corp-Aktie (EW)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):